BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial

Bria-OTS™ would build on BriaCell’s existing clinical trial data with Bria-IMT™, treating each patient with the optimized pre-manufactured Bria-OTS™ formulation based on HLA-type.